Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alphafetoprotein”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Testing effectiveness (Phase 2)Looking for participantsNCT07289997
What this trial is testing

Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC)

Who this might be right for
AFP Gastric or Gastroesophageal Junction AdenocarcinomaPD-1/CTLA-4AFPGC+1 more
Hebei Medical University Fourth Hospital 39
Not applicableStudy completedNCT00065897
What this trial is testing

Prenatal Testing: Amniocentesis Versus Transabdominal Chorionic Villus Sampling (TA CVS)

Who this might be right for
Pregnancy
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 6,400
Not applicableStudy completedNCT03047603
What this trial is testing

Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 4,005
Not applicableNot Yet RecruitingNCT06331260
What this trial is testing

Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma

Who this might be right for
Liver TransplantationHepatocellular CarcinomaAlpha-Fetoprotein+1 more
Zhejiang University 600
Not applicableUnknownNCT05764551
What this trial is testing

The Application of Serum DNA Methylation for Patients With HCC

Who this might be right for
Hepatocellular Carcinoma
Chiayi Christian Hospital 100
Not applicableLooking for participantsNCT07469319
What this trial is testing

Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis

Who this might be right for
Hepatocellular Carcinoma (HCC)Cirrhosis
University of Aarhus 617
Post-approval studies (Phase 4)Looking for participantsNCT06084234
What this trial is testing

National Liver Cancer Screening Trial

Who this might be right for
Carcinoma, HepatocellularLiver CancerLiver Cirrhosis+1 more
University of Texas Southwestern Medical Center 5,500
Not applicableStudy completedNCT05559229
What this trial is testing

Poorly Differentiated Adenocarcinoma With Signet Ring Cells of the Gallbladder Producing a High Level of Alpha-fetoprotein: a Case Report

Who this might be right for
Gallbladder Cancer
junya mita 1
Early research (Phase 1)Study completedNCT03132792
What this trial is testing

AFPᶜ³³²T in Advanced HCC

Who this might be right for
Hepatocellular CancerAFP Expressing Tumors
Adaptimmune 39
Not applicableStudy completedNCT05200195
What this trial is testing

Deep Learning Model for the Prediction of Post-LT HCC Recurrence

Who this might be right for
Liver Transplant DisorderLiver CancerRecurrent Cancer
European Hepatocellular Cancer Liver Transplant Group 4,026
Not applicableUnknownNCT00006445
What this trial is testing

Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters

Who this might be right for
Down SyndromeChromosome Abnormalities
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 38,000
Not applicableUnknownNCT01350167
What this trial is testing

Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease

Who this might be right for
CirrhosisEnd Stage Liver DiseaseHepatitis C
Minneapolis Veterans Affairs Medical Center 300
Testing effectiveness (Phase 2)Looking for participantsNCT06427941
What this trial is testing

BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more
BeOne Medicines 630
Testing effectiveness (Phase 2)Study completedNCT00005629
What this trial is testing

Vaccine Therapy in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Jonsson Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)UnknownNCT01377220
What this trial is testing

Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Commissariat A L'energie Atomique 30
Testing effectiveness (Phase 2)Ended earlyNCT01128803
What this trial is testing

Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response

Who this might be right for
Hepatocellular Carcinoma
Nantes University Hospital 1
Not applicableNot Yet RecruitingNCT07764835
What this trial is testing

Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisChronic Hepatitis B+2 more
D'Or Institute for Research and Education 300
Not applicableUnknownNCT04082507
What this trial is testing

Maternal Serum Alpha-fetoprotein Level May Predict the Presence of Morbid Adherent Placenta

Who this might be right for
Placenta Accreta
rasha medhat abdul-hady 150
Not applicableUnknownNCT01009723
What this trial is testing

Preterm Delivery Risk Prediction by Measurement of Prenatal Serum Screening Markers

Who this might be right for
Preterm Delivery
Esoterix Genetic Laboratories, LLC 2,000
Not applicableUnknownNCT01846949
What this trial is testing

Surveillance Study for HCC by Combining Biomarkers With Imaging (ALDUS)

Who this might be right for
Liver Cirrhosis
ALDUS Study Group 1,000
Next Page